Biotasmart

biotasmart.com ↗ ·Valencia ·Seed

Biotasmart is a Valencia-based healthtech/biotech startup that turns gut microbiota sequencing data into personalised, clinically actionable nutrition and supplementation recommendations. It sells B2B to doctors, dietitian-nutritionists, longevity clinics, women's health centres and sports performance facilities, with a consumer-facing at-home test and an advanced shotgun-metagenomics test. Founded in 2024, accelerated by Lanzadera, it closed a €500,000 round in early 2026 led by Juan Roig's Angels Capital.

Founded

2024

Founders

Total funds raised

€500K

SectorsHealthtech, Biotech, Microbiome, Personalized Nutrition, Wellness, B2B SaaS Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing

Suggest a correction

Founders

María Gómez

Co-founder & CPO

Olga Carbonell

Founder & CEO

Global models 5

Viome

United States · www.viome.com ↗

Sequences the gut microbiome (metatranscriptomics) from home test kits and turns the results into personalised food and supplement recommendations, sold to consumers and through clinicians.

$200M+Comparable

ZOE

United Kingdom · zoe.com ↗

Combines a gut microbiome test with other biomarker data to give personalised nutrition advice, sold as a consumer test plus programme.

$118M+Comparable

DayTwo

Israel · www.daytwo.com ↗

Uses gut microbiome sequencing to predict how each person's blood sugar responds to food and gives personalised nutrition plans, sold B2B to health plans, employers and clinicians.

$90MComparable

Microba Life Sciences

Australia · www.microba.com ↗

Runs shotgun-metagenomics gut microbiome tests that practitioners order and read to guide nutrition and supplement treatment, the same clinician-channel model as Biotasmart.

$60M+Comparable

Tiny Health

United States · www.tinyhealth.com ↗

Offers at-home shotgun-metagenomics gut tests with clinically actionable diet and supplement guidance, sold to consumers and through a practitioner programme, with a focus on women's and children's health.

$10M+Comparable